Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04261894 · ClinicalTrials.gov registry record · NA
The OPTIMIZE Study: Optimizing Patient Navigation for Perinatal Care
A NA study of Pregnancy Related, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 548
- Enrollment target
- 1
- Study location
NCT04261894: Active NA study of Pregnancy Related, sponsored by Northwestern University.
NCT04261894 is a NA study of Pregnancy Related that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 548 participants, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04261894, a NA study of Pregnancy Related, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 548 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will develop and test an intervention, called OPTIMIZE, which includes the use of a perinatal checklist by clinic staff and provision of patient navigation support to African American pregnant women. Half of the clinics in the study will be assigned to the OPTIMIZE intervention and half will administer standard care.
Primary Outcome
The primary outcome will be a composite proportion of perinatal care components across three domains, including prenatal care, postpartum care, and social determinants of health content compared between the intervention and control arms.
Conditions Studied
Interventions
- BEHAVIORAL OPTIMIZE
Study Locations (1)
Illinois
- ACCESS Community Health Network - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 548 participants |
| Start Date | 2021-06-23 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the registry record for NCT04261894 still lists
NCT04261894 is an interventional study that assigns participants to a tested intervention. The registered 548 participants enrollment target is mid-sized for trials with a published cap, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which OPTIMIZE is the first listed.
NCT04261894 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04261894 about?
NCT04261894 is a clinical study titled "The OPTIMIZE Study: Optimizing Patient Navigation for Perinatal Care". This study will develop and test an intervention, called OPTIMIZE, which includes the use of a perinatal checklist by clinic staff and provision of patient navigation support to African American pregnant women. Half of the clinics in the study will be assigned to the OPTIMIZE intervention and half w...
What is the current status of trial NCT04261894?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 548 participants. The study started on 2021-06-23. Estimated completion is 2025-09-30.
What conditions does trial NCT04261894 study?
This clinical trial studies the following conditions: Pregnancy Related.
What interventions are being tested in trial NCT04261894?
The interventions under investigation include: OPTIMIZE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04261894?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04261894 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04261894's enrollment target sits among peer trials
548 26th of 99 higher than 74 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI